In recent years, multiple probiotics have been tested in randomized controlled trials for IBS (Irritable Bowel Syndrome), but due to differences in strain tested and methodology, making recommendations concerning which probiotics are beneficial for the management of IBS has been difficult to date.
A new well-conducted meta-analysis by renowned gastroenterology experts has been published in the most prominent journal for the field: Gastroenterology, the official journal of the American Gastroenterological Association.
In this study, the authors assessed three endpoints in IBS populations: global symptoms—abdominal pain—bloating, or distension.
Discover the key facts on the study and how S. cerevisiae CNCM I-3856 is now acknowledged as one of the most documented probiotic strains for IBS symptom management, specifically for abdominal pain.
Deep Dive Into Probiotics
Curious about how probiotic bacteria in your gut can impact your digestion and immune health? Find out more in this article to uncover the amazing benefits of these tiny microorganisms for your well-being.
